226 lung adenocarcinoma samples and 20 normal lung tissues were analyzed. Sample data includes EGFR mutation, KRAS mutation, EML4-ALK gene fusion, stage, recurrence, survival status, and others. This evidence concerns the gene ALK and lung adenocarcinoma.